{"cord_uid":"ehnu83qe", "sourcedb":"PMC", "sourceid":"PMC4546680", "divid":10, "text":"To detect the specificity of antibodies against CMV, CMV-3A as ligand was immobilized on two columns (Fig 1) . PBST buffer was added as blank control to two areas on the first row. Simultaneously, purified CMV antibody (0.1 mg/mL) was added as positive control to two areas on the second row. Normal serum without CMV antibodies was added as negative control to two areas on the third row. Three patient serum samples (No. 956, 933, and 978; see Table A in S2 File for sample information) were analyzed on the following rows, respectively.", "project":"cdlai_CORD-19", "denotations":[]}